The quest for an evidence-based approach to intermediate-risk prostate cancer

Theodore R. Saitz; Jen Jane Liu

The quest for an evidence-based approach to intermediate-risk prostate cancer

Theodore R. Saitz, Jen Jane Liu

Urology

Research output: Contribution to journal › Article › peer-review

Abstract

We must now come to a uniform consensus regarding the descriptions of these risk groups in order to truly determine which treatments have the best oncologic efficacy, while minimizing overtreatment and optimizing patients’ quality of life.

Original language	English (US)
Journal	ONCOLOGY (United States)
Volume	30
Issue number	3
State	Published - Mar 15 2016

ASJC Scopus subject areas

Oncology
Cancer Research

Cite this

@article{ffc539e9283a4051bf1d07f56290d0de,

title = "The quest for an evidence-based approach to intermediate-risk prostate cancer",

abstract = "We must now come to a uniform consensus regarding the descriptions of these risk groups in order to truly determine which treatments have the best oncologic efficacy, while minimizing overtreatment and optimizing patients{\textquoteright} quality of life.",

author = "Saitz, {Theodore R.} and Liu, {Jen Jane}",

year = "2016",

month = mar,

day = "15",

language = "English (US)",

volume = "30",

journal = "ONCOLOGY (United States)",

issn = "0890-9091",

publisher = "UBM Medica Healthcare Publications",

number = "3",

}

TY - JOUR

T1 - The quest for an evidence-based approach to intermediate-risk prostate cancer

AU - Saitz, Theodore R.

AU - Liu, Jen Jane

PY - 2016/3/15

Y1 - 2016/3/15

N2 - We must now come to a uniform consensus regarding the descriptions of these risk groups in order to truly determine which treatments have the best oncologic efficacy, while minimizing overtreatment and optimizing patients’ quality of life.

AB - We must now come to a uniform consensus regarding the descriptions of these risk groups in order to truly determine which treatments have the best oncologic efficacy, while minimizing overtreatment and optimizing patients’ quality of life.

UR - http://www.scopus.com/inward/record.url?scp=84979000350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979000350&partnerID=8YFLogxK

M3 - Article

C2 - 26984217

AN - SCOPUS:84979000350

SN - 0890-9091

VL - 30

JO - ONCOLOGY (United States)

JF - ONCOLOGY (United States)

IS - 3

ER -

The quest for an evidence-based approach to intermediate-risk prostate cancer

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this